Department of Endocrinology, Iuliu Haţieganu University of Medicine and Pharmacy , Cluj-Napoca, Romania.
5th Department of Internal Medicine, Iuliu Haţieganu University of Medicine and Pharmacy , Cluj-Napoca, Romania.
Acta Clin Belg. 2021 Feb;76(1):40-48. doi: 10.1080/17843286.2019.1660021. Epub 2019 Aug 24.
: The mechanisms of obesity-associated thyroid dysfunction in children are incompletely deciphered. We aimed to evaluate whether visceral adipose tissue (VAT), insulin resistance (IR), inflammation, oxidative stress (OS) are involved in thyroid morpho-functional changes in pubertal obese children. : We recruited 43 obese pubertal children without history of thyroid pathology. Metabolic and thyroid parameters (visceral fat thickness [VFT], waist/hip ratio [WHR], waist/height ratio [WHtR], insulin, glucose, liver parameters, thyroid stimulation hormone [TSH], free thyroxine [FT4], free triiodothyronine [FT3], thyroid and abdominal ultrasonography) were evaluated. Serum monocyte chemoattractant protein-1 (MCP-1) and malondialdehyde (MDA) levels were quantified as markers of inflammation and OS. : VFT correlated positively both with WHR (p= 0.034) and the presence of thyroid nodules (p= 0.036). WHR associated with TSH (p= 0.005), FT3/FT4 (p= 0.033) and was independently associated with FT3/FT4 increase (p< 0.001). HOMA-IR increased with visceral obesity (waist circumference, p= 0.001; WHR, p= 0.018; WHtR: p< 0.001), hepatic impairment (alanine aminotransferase, p= 0.019) and hepatic steatosis (HS; p= 0.013) and correlated positively with FT3/FT4 (p= 0.036). TSH was significantly higher in subjects with HS versus those without HS (p= 0.007) and logistic regression analysis identified TSH as a risk factor for HS (p= 0.014). MDA correlated positively with MCP-1 (p= 0.021). : VAT and IR may be responsible for changes in thyroid parameters associated with obesity: elevated TSH, FT3/FT4 levels and increased prevalence of thyroid nodules. WHR was predictive of increased FT3/FT4. In obese children, there is an interdependent relationship between HS and thyroid function.
肥胖相关甲状腺功能障碍的机制尚未完全阐明。我们旨在评估内脏脂肪组织 (VAT)、胰岛素抵抗 (IR)、炎症、氧化应激 (OS) 是否参与青春期肥胖儿童的甲状腺形态和功能变化。
我们招募了 43 名无甲状腺病史的肥胖青春期儿童。评估了代谢和甲状腺参数(内脏脂肪厚度 [VFT]、腰臀比 [WHR]、腰高比 [WHtR]、胰岛素、葡萄糖、肝脏参数、促甲状腺激素 [TSH]、游离甲状腺素 [FT4]、游离三碘甲状腺原氨酸 [FT3]、甲状腺和腹部超声)。血清单核细胞趋化蛋白 1 (MCP-1) 和丙二醛 (MDA) 水平作为炎症和 OS 的标志物进行了量化。
VFT 与 WHR 呈正相关(p=0.034),与甲状腺结节的存在也呈正相关(p=0.036)。WHR 与 TSH 相关(p=0.005),与 FT3/FT4 相关(p=0.033),并与 FT3/FT4 升高独立相关(p<0.001)。HOMA-IR 随内脏肥胖增加(腰围,p=0.001;WHR,p=0.018;WHtR:p<0.001)、肝损伤(丙氨酸氨基转移酶,p=0.019)和肝脂肪变性(HS;p=0.013),与 FT3/FT4 呈正相关(p=0.036)。与无 HS 者相比,HS 患者的 TSH 显著升高(p=0.007),逻辑回归分析确定 TSH 是 HS 的危险因素(p=0.014)。MDA 与 MCP-1 呈正相关(p=0.021)。
VAT 和 IR 可能是导致肥胖相关甲状腺参数变化的原因:TSH 升高、FT3/FT4 水平升高和甲状腺结节患病率增加。WHR 可预测 FT3/FT4 升高。在肥胖儿童中,HS 与甲状腺功能之间存在相互依存的关系。